Participants with a serum albumin <3.5 g/dL at SGLT2i initiation were less likely to achieve a ≥30% reduction in proteinuria during follow-up, indicating limited response in those with active nephrotic syndrome. This evidence concerns the gene ALB and nephrotic syndrome.